The Regulation of Deubiquitinases by Oxidative Stress in Saccharomyces

Total Page:16

File Type:pdf, Size:1020Kb

The Regulation of Deubiquitinases by Oxidative Stress in Saccharomyces The regulation of deubiquitinases by oxidative stress in Saccharomyces cerevisiae. Faye Elizabeth Jade Curtis Thesis submitted for the degree of Doctor of Philosophy Institute for Cell and Molecular Biosciences Faculty of Medical Sciences Newcastle University September 2018 Declaration I certify that this thesis is my own work, except where acknowledged. Work in this thesis has not been previously submitted for another degree or qualification at this or any other university. [i] [ii] Abstract Reactive oxygen species (ROS) are produced as by-products of cellular processes. In eukaryotes high levels of ROS cause oxidative stress, leading to intracellular damage and age-related diseases, whereas low levels of ROS are vital for many cellular functions including signal transduction and cell proliferation. It is therefore essential that cells can sense the different types and levels of ROS to ensure that they respond in an appropriate manner. Ubiquitination is a post- translational modification which plays vital roles in fundamental cellular processes, including protein degradation and many signalling pathways. Ubiquitination of substrates occurs in a cycle involving the coordinated activity of conjugation and deconjugation enzymes and, interestingly, most ubiquitin pathway enzymes utilise catalytic cysteines for function. Recent work from our lab and others has begun to reveal that the relative sensitivity of these cysteines to oxidation is important for sensing the different types and levels of ROS. In the present study we hypothesised that deubiquitinases (dUbs), which remove ubiquitin from substrates through the activity of an active site catalytic cysteine, may also be regulated by ROS. Hence to test this hypothesis, the tractability and powerful genetic tools available in the model eukaryote Saccharomyces cerevisiae were utilised to investigate the potential regulation and function of all dUbs in this organism in response to different oxidising agents. Excitingly, an initial screen of available S. cerevisiae dUb gene deletion mutants and strains expressing epitope-tagged dUbs identified wide and varied responses of dUbs to different oxidising agents. For example, several dUbs were found to be important for cell survival under different oxidative stress conditions. Furthermore, specific dUbs were also found to be modified in response to specific oxidising agents. In particular, further investigations into specific dUbs observed that Ubp12 was reversibly oxidised into a HMW intramolecular disulphide complex in response to H2O2 but no other oxidising agents tested. Significantly, the catalytic cysteine of Ubp12 was shown to be essential for this complex, suggesting that oxidation regulates Ubp12 activity. Another dUb, Ubp2, was also found to be oxidised in response to H2O2. Other work has shown that Ubp2 and Ubp12 regulate mitochondrial dynamics, and therefore the present study led to a model [iii] suggesting that the regulation of Ubp12 and Ubp2 by H2O2 may regulate mitochondrial dynamics in response to different levels of H2O2. In contrast to Ubp2 and Ubp12, further investigations into another dUb, Ubp15, was found to be oxidised into HMW complexes in response to both H2O2 and diamide. Interestingly, these Ubp15 HMW complexes have different mobilities suggesting differences in the way Ubp15 responds to different oxidising agents. Significantly, similar to Ubp12, the catalytic cysteine of Ubp15 was essential for the formation of the H2O2-induced HMW complex. Ubp15 has previously been implicated in the regulation of cell cycle progression, and consistent with this link the present results suggest that Ubp15 may be important for regulating G1 phase arrest/delay, and for regulating the release into S phase, following H2O2 treatment. Collectively, the work described here has begun to provide insight into how cells sense and respond to different types and levels of ROS by regulating specific dUbs. Furthermore, the yeast dUbs are conserved in higher eukaryotes and hence these studies have potential implications for the regulation of fundamental processes such as the cell cycle and mitochondrial dynamics. [iv] Acknowledgements Firstly, I would like to thank my supervisor Brian Morgan, for his constant support, advice, enthusiasm, and total confidence in me throughout this PhD. I would also like to acknowledge the BBSRC for funding my research, and David Stead at Aberdeen University for completing the mass spectrometry and computational analysis. Secondly, I would like to thank everyone in the Morgan, Quinn, Whitehall, and Veal labs, past and present, for helping with ideas and insight in this project. But more importantly for providing cake, chocolate and for making the four years fun! I would especially like to thank Callum- for keeping me sane (ish!), and Zoe-for the much needed coffee breaks, wine nights and random chat. Thirdly, I would like to thank my family, Mam and Dad, and even you Scall, for the encouragement and support over all the years and for providing endless love (and gin) to get me to here. Finally, I would like to thank Luke. You have been there to celebrate the good days and to cheer me up after the bad days. You have made everything better, and I definitely couldn’t have done it without you. [v] [vi] Table of Contents Declaration ......................................................................................................... i Abstract ........................................................................................................ iii Acknowledgements ............................................................................................... v Table of Contents ................................................................................................. vii Abbreviations ...................................................................................................... xiii List of Figures ...................................................................................................... xv List of Tables ...................................................................................................... xix Chapter One: Introduction ..................................................................................... 1 1.1. Ubiquitin and ubiquitin-like modifications…………………….... ………......1 1.1.1. Ubiquitin and ubiquitin-like conjugation .................................... …...……..3 1.1.1.1. Ubiquitin conjugation ....................................................................... 3 1.1.1.2. Types of ubiquitin conjugation ....................................................... 10 1.1.1.2.1. Mono- and multi-ubiquitination ....................................................... 10 1.1.1.2.2. Poly-ubiquitination ......................................................................... 13 1.1.1.3. Targets and functions of ubiquitination .......................................... 15 1.1.1.3.1. Ubiquitination and cell cycle regulation .......................................... 15 1.1.1.3.2. Ubiquitination and DNA repair ....................................................... 16 1.1.1.3.3. Ubiquitination and protein localisation ........................................... 17 1.1.1.3.4. Ubiquitination and mitochondrial regulation ................................... 17 1.1.1.4. Ubiquitin-like modifications ............................................................ 18 1.1.2. Deubiquitination ..................................................................................... 20 1.1.2.1. JAMM family .................................................................................. 23 1.1.2.2. USP family ..................................................................................... 24 1.1.2.3. UCH family ..................................................................................... 27 1.1.2.4. OTU family ..................................................................................... 27 1.1.2.5. DUb specificity ............................................................................... 28 1.1.2.5.1. Ubiquitin vs ubiquitin-like specificity ............................................... 28 1.1.2.5.2. Substrate specificity ....................................................................... 29 1.1.2.5.3. Type of chain linkage ..................................................................... 29 1.1.2.5.4. Protein partners ............................................................................. 31 1.1.2.5.5. Outstanding questions about dUb specificity ................................. 32 1.1.2.6. DUbs in disease ............................................................................. 32 1.1.3. Regulation of ubiquitin/ubiquitin-like pathway enzymes ......................... 33 1.2. Reactive oxygen species ....................................................................... 35 [vii] 1.2.1. Types and sources of ROS..................................................................... 35 1.2.1.1. The mitochondrial electron transport chain .................................... 36 1.2.1.2. Transition metals ............................................................................ 37 1.2.1.3. The immune response ................................................................... 37 1.2.1.4. Xenobiotics..................................................................................... 39 1.2.1.5. UV and ionising radiation ............................................................... 40 1.2.2. Effects of ROS .......................................................................................
Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Untying the Knot: Protein Quality Control in Inherited Cardiomyopathies
    Pflügers Archiv - European Journal of Physiology https://doi.org/10.1007/s00424-018-2194-0 INVITED REVIEW Untying the knot: protein quality control in inherited cardiomyopathies Larissa M. Dorsch1 & Maike Schuldt1 & Dora Knežević1 & Marit Wiersma1 & Diederik W. D. Kuster1 & Jolanda van der Velden1 & Bianca J. J. M. Brundel1 Received: 30 July 2018 /Accepted: 6 August 2018 # The Author(s) 2018 Abstract Mutations in genes encoding sarcomeric proteins are the most important causes of inherited cardiomyopathies, which are a major cause of mortality and morbidity worldwide. Although genetic screening procedures for early disease detection have been improved significantly, treatment to prevent or delay mutation-induced cardiac disease onset is lacking. Recent findings indicate that loss of protein quality control (PQC) is a central factor in the disease pathology leading to derailment of cellular protein homeostasis. Loss of PQC includes impairment of heat shock proteins, the ubiquitin-proteasome system, and autophagy. This may result in accumulation of misfolded and aggregation-prone mutant proteins, loss of sarcomeric and cytoskeletal proteins, and, ultimately, loss of cardiac function. PQC derailment can be a direct effect of the mutation-induced activation, a compensa- tory mechanism due to mutation-induced cellular dysfunction or a consequence of the simultaneous occurrence of the mutation and a secondary hit. In this review, we discuss recent mechanistic findings on the role of proteostasis derailment in inherited cardiomyopathies, with special focus on sarcomeric gene mutations and possible therapeutic applications. Keywords Cardiomyopathy .Proteinqualitycontrol .Sarcomericmutation .Heatshockproteins .Ubiquitin-proteasomesystem . Autophagy Classification of cardiomyopathies occurring asymmetrically, and dilated CM (DCM), in which the presence of LV dilatation is accompanied by contractile Cardiomyopathies (CM) constitute one of the most common dysfunction [24].
    [Show full text]
  • Supporting Information
    Supporting Information Figure S1. The functionality of the tagged Arp6 and Swr1 was confirmed by monitoring cell growth and sensitivity to hydeoxyurea (HU). Five-fold serial dilutions of each strain were plated on YPD with or without 50 mM HU and incubated at 30°C or 37°C for 3 days. Figure S2. Localization of Arp6 and Swr1 on chromosome 3. The binding of Arp6-FLAG (top), Swr1-FLAG (middle), and Arp6-FLAG in swr1 cells (bottom) are compared. The position of Tel 3L, Tel 3R, CEN3, and the RP gene are shown under the panels. Figure S3. Localization of Arp6 and Swr1 on chromosome 4. The binding of Arp6-FLAG (top), Swr1-FLAG (middle), and Arp6-FLAG in swr1 cells (bottom) in the whole chromosome region are compared. The position of Tel 4L, Tel 4R, CEN4, SWR1, and RP genes are shown under the panels. Figure S4. Localization of Arp6 and Swr1 on the region including the SWR1 gene of chromosome 4. The binding of Arp6- FLAG (top), Swr1-FLAG (middle), and Arp6-FLAG in swr1 cells (bottom) are compared. The position and orientation of the SWR1 gene is shown. Figure S5. Localization of Arp6 and Swr1 on chromosome 5. The binding of Arp6-FLAG (top), Swr1-FLAG (middle), and Arp6-FLAG in swr1 cells (bottom) are compared. The position of Tel 5L, Tel 5R, CEN5, and the RP genes are shown under the panels. Figure S6. Preferential localization of Arp6 and Swr1 in the 5′ end of genes. Vertical bars represent the binding ratio of proteins in each locus.
    [Show full text]
  • Supplementary Tables
    Supplementary Tables Supplementary Table S1: Preselected miRNAs used in feature selection Univariate Cox proportional hazards regression analysis of the endpoint freedom from recurrence in the training set (DKTK-ROG sample) allowed the pre-selection of 524 miRNAs (P< 0.5), which were used in the feature selection. P-value was derived from log-rank test. miRNA p-value miRNA p-value miRNA p-value miRNA p-value hsa-let-7g-3p 0.0001520 hsa-miR-1304-3p 0.0490161 hsa-miR-7108-5p 0.1263245 hsa-miR-6865-5p 0.2073121 hsa-miR-6825-3p 0.0004257 hsa-miR-4298 0.0506194 hsa-miR-4453 0.1270967 hsa-miR-6893-5p 0.2120664 hsa-miR-668-3p 0.0005188 hsa-miR-484 0.0518625 hsa-miR-200a-5p 0.1276345 hsa-miR-25-3p 0.2123829 hsa-miR-3622b-3p 0.0005885 hsa-miR-6851-3p 0.0531446 hsa-miR-6090 0.1278692 hsa-miR-3189-5p 0.2136060 hsa-miR-6885-3p 0.0006452 hsa-miR-1276 0.0557418 hsa-miR-148b-3p 0.1279811 hsa-miR-6073 0.2139702 hsa-miR-6875-3p 0.0008188 hsa-miR-3173-3p 0.0559962 hsa-miR-4425 0.1288330 hsa-miR-765 0.2141536 hsa-miR-487b-5p 0.0011381 hsa-miR-650 0.0564616 hsa-miR-6798-3p 0.1293342 hsa-miR-338-5p 0.2153079 hsa-miR-210-5p 0.0012316 hsa-miR-6133 0.0571407 hsa-miR-4472 0.1300006 hsa-miR-6806-5p 0.2173515 hsa-miR-1470 0.0012822 hsa-miR-4701-5p 0.0571720 hsa-miR-4465 0.1304841 hsa-miR-98-5p 0.2184947 hsa-miR-6890-3p 0.0016539 hsa-miR-202-3p 0.0575741 hsa-miR-514b-5p 0.1308790 hsa-miR-500a-3p 0.2185577 hsa-miR-6511b-3p 0.0017165 hsa-miR-4733-5p 0.0616138 hsa-miR-378c 0.1317442 hsa-miR-4515 0.2187539 hsa-miR-7109-3p 0.0021381 hsa-miR-595 0.0629350 hsa-miR-3121-3p
    [Show full text]
  • (Ubl-Ptms): Small Peptides with Huge Impact in Liver Fibrosis
    cells Review Ubiquitin-Like Post-Translational Modifications (Ubl-PTMs): Small Peptides with Huge Impact in Liver Fibrosis 1 1, 1, Sofia Lachiondo-Ortega , Maria Mercado-Gómez y, Marina Serrano-Maciá y , Fernando Lopitz-Otsoa 2, Tanya B Salas-Villalobos 3, Marta Varela-Rey 1, Teresa C. Delgado 1,* and María Luz Martínez-Chantar 1 1 Liver Disease Lab, CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160 Derio, Spain; [email protected] (S.L.-O.); [email protected] (M.M.-G.); [email protected] (M.S.-M.); [email protected] (M.V.-R.); [email protected] (M.L.M.-C.) 2 Liver Metabolism Lab, CIC bioGUNE, 48160 Derio, Spain; fl[email protected] 3 Department of Biochemistry and Molecular Medicine, School of Medicine, Autonomous University of Nuevo León, Monterrey, Nuevo León 66450, Mexico; [email protected] * Correspondence: [email protected]; Tel.: +34-944-061318; Fax: +34-944-061301 These authors contributed equally to this work. y Received: 6 November 2019; Accepted: 1 December 2019; Published: 4 December 2019 Abstract: Liver fibrosis is characterized by the excessive deposition of extracellular matrix proteins including collagen that occurs in most types of chronic liver disease. Even though our knowledge of the cellular and molecular mechanisms of liver fibrosis has deeply improved in the last years, therapeutic approaches for liver fibrosis remain limited. Profiling and characterization of the post-translational modifications (PTMs) of proteins, and more specifically NEDDylation and SUMOylation ubiquitin-like (Ubls) modifications, can provide a better understanding of the liver fibrosis pathology as well as novel and more effective therapeutic approaches.
    [Show full text]
  • Chlamydia Trachomatis-Containing Vacuole Serves As Deubiquitination
    RESEARCH ARTICLE Chlamydia trachomatis-containing vacuole serves as deubiquitination platform to stabilize Mcl-1 and to interfere with host defense Annette Fischer1, Kelly S Harrison2, Yesid Ramirez3, Daniela Auer1, Suvagata Roy Chowdhury1, Bhupesh K Prusty1, Florian Sauer3, Zoe Dimond2, Caroline Kisker3, P Scott Hefty2, Thomas Rudel1* 1Department of Microbiology, Biocenter, University of Wu¨ rzburg, Wu¨ rzburg, Germany; 2Department of Molecular Biosciences, University of Kansas, lawrence, United States; 3Rudolf Virchow Center for Experimental Biomedicine, University of Wu¨ rzburg, Wu¨ rzburg, Germany Abstract Obligate intracellular Chlamydia trachomatis replicate in a membrane-bound vacuole called inclusion, which serves as a signaling interface with the host cell. Here, we show that the chlamydial deubiquitinating enzyme (Cdu) 1 localizes in the inclusion membrane and faces the cytosol with the active deubiquitinating enzyme domain. The structure of this domain revealed high similarity to mammalian deubiquitinases with a unique a-helix close to the substrate-binding pocket. We identified the apoptosis regulator Mcl-1 as a target that interacts with Cdu1 and is stabilized by deubiquitination at the chlamydial inclusion. A chlamydial transposon insertion mutant in the Cdu1-encoding gene exhibited increased Mcl-1 and inclusion ubiquitination and reduced Mcl- 1 stabilization. Additionally, inactivation of Cdu1 led to increased sensitivity of C. trachomatis for IFNg and impaired infection in mice. Thus, the chlamydial inclusion serves as an enriched site for a *For correspondence: thomas. deubiquitinating activity exerting a function in selective stabilization of host proteins and [email protected]. protection from host defense. de DOI: 10.7554/eLife.21465.001 Competing interests: The authors declare that no competing interests exist.
    [Show full text]
  • Computational Modeling of Lysine Post-Translational Modification: an Overview Md
    c and S eti ys h te nt m y s S B Hasan MM et al., Curr Synthetic Sys Biol 2018, 6:1 t i n o e l Current Synthetic and o r r g DOI: 10.4172/2332-0737.1000137 u y C ISSN: 2332-0737 Systems Biology CommentaryResearch Article OpenOpen Access Access Computational Modeling of Lysine Post-Translational Modification: An Overview Md. Mehedi Hasan 1*, Mst. Shamima Khatun2, and Hiroyuki Kurata1,3 1Department of Bioscience and Bioinformatics, Kyushu Institute of Technology, 680-4 Kawazu, Iizuka, Fukuoka 820-8502, Japan 2Department of Statistics, Laboratory of Bioinformatics, Rajshahi University-6205, Bangladesh 3Biomedical Informatics R&D Center, Kyushu Institute of Technology, 680-4 Kawazu, Iizuka, Fukuoka 820-8502, Japan Commentary hot spot for PTMs, and a number of protein lysine modifications could occur in both histone and non-histone proteins [11,12]. For instance, Living organisms have a magnificent ordered and complex lysine methylation in non-histone proteins can regulate the protein structure. In regulating the cellular functions, post-translational activity and protein structure stability [13]. In 2004, the Nobel Prize in modifications (PTMs) are critical molecular measures. They alter Chemistry was awarded jointly to Aaron Ciechanover, Avram Hershko protein conformation, modulating their activity, stability and and Irwin Rose for the discovery of lysine ubiquitin-mediated protein localization. Up to date, more than 300 types of PTMs are experimentally degradation [14]. discovered in vivo and in vitro pathways [1,2]. Major and common PTMs are methylation, ubiquitination, succinylation, phosphorylation, Moreover, in biological process, lysine can be modified by the glycosylation, acetylation, and sumoylation.
    [Show full text]
  • The Effect of the URM1 Pathway on Translation by Thiolation of Specific Trnas
    Research Collection Doctoral Thesis The effect of the URM1 pathway on translation by thiolation of specific tRNAs Author(s): Rezgui, Vanessa Anissa Nathalie Publication Date: 2012 Permanent Link: https://doi.org/10.3929/ethz-a-007624233 Rights / License: In Copyright - Non-Commercial Use Permitted This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library DISS. ETH NO. 20870 The effect of the URM1 pathway on translation by thiolation of specific tRNAs A dissertation submitted to ETH ZURICH for the degree of Doctor of Sciences presented by Vanessa Anissa Nathalie Rezgui M.Sc. University of Geneva born on April, 28th 1981 citizen of Switzerland (Zurich) accepted on the recommendation of Prof. Matthias Peter – examiner Prof. André Gerber – co-examiner Prof. Paola Picotti – co-examiner 2012 TABLE OF CONTENTS SUMMARY ........................................................................................................ 4 RESUMÉ ............................................................................................................ 5 1 Introduction. ............................................................................................... 6 1.1 Translation............................................................................................................................................ 6 1.2 Translation regulation......................................................................................................................
    [Show full text]
  • Loss of Conserved Ubiquitylation Sites in Conserved Proteins During Human Evolution
    INTERNATIONAL JOURNAL OF MOleCular meDICine 42: 2203-2212, 2018 Loss of conserved ubiquitylation sites in conserved proteins during human evolution DONGBIN PARK, CHUL JUN GOH, HYEIN KIM, JI SEOK LEE and YOONSOO HAHN Department of Life Science, Chung‑Ang University, Seoul 06974, Republic of Korea Received January 30, 2018; Accepted July 6, 2018 DOI: 10.3892/ijmm.2018.3772 Abstract. Ubiquitylation of lysine residues in proteins serves Introduction a pivotal role in the efficient removal of misfolded or unused proteins and in the control of various regulatory pathways Ubiquitylation, in which the highly conserved 76‑residue poly- by monitoring protein activity that may lead to protein peptide ubiquitin is covalently attached to a lysine residue of degradation. The loss of ubiquitylated lysines may affect substrate proteins, mediates the targeted destruction of ubiq- the ubiquitin‑mediated regulatory network and result in the uitylated proteins by the ubiquitin‑proteasome system (1‑4). emergence of novel phenotypes. The present study analyzed The ubiquitin‑mediated protein degradation pathway serves a mouse ubiquitylation data and orthologous proteins from crucial role in the efficient and specific removal of misfolded 62 mammals to identify 193 conserved ubiquitylation sites from proteins and certain key regulatory proteins (5,6). Ubiquitin 169 proteins that were lost in the Euarchonta lineage leading and other ubiquitin‑like proteins, including autophagy‑related to humans. A total of 8 proteins, including betaine homo- protein 8, Ubiquitin‑like
    [Show full text]
  • Molecular Chaperones & Stress Responses
    Abstracts of papers presented at the 2010 meeting on MOLECULAR CHAPERONES & STRESS RESPONSES May 4–May 8, 2010 CORE Metadata, citation and similar papers at core.ac.uk Provided by Cold Spring Harbor Laboratory Institutional Repository Cold Spring Harbor Laboratory Cold Spring Harbor, New York Abstracts of papers presented at the 2010 meeting on MOLECULAR CHAPERONES & STRESS RESPONSES May 4–May 8, 2010 Arranged by F. Ulrich Hartl, Max Planck Institute for Biochemistry, Germany David Ron, New York University School of Medicine Jonathan Weissman, HHMI/University of California, San Francisco Cold Spring Harbor Laboratory Cold Spring Harbor, New York This meeting was funded in part by the National Institute on Aging; the National Heart, Lung and Blood Institute; and the National Institute of General Medical Sciences; branches of the National Institutes of Health; and Enzo Life Sciences, Inc. Contributions from the following companies provide core support for the Cold Spring Harbor meetings program. Corporate Sponsors Agilent Technologies Life Technologies (Invitrogen & AstraZeneca Applied Biosystems) BioVentures, Inc. Merck (Schering-Plough) Research Bristol-Myers Squibb Company Laboratories Genentech, Inc. New England BioLabs, Inc. GlaxoSmithKline OSI Pharmaceuticals, Inc. Hoffmann-La Roche Inc. Sanofi-Aventis Plant Corporate Associates Monsanto Company Pioneer Hi-Bred International, Inc. Foundations Hudson-Alpha Institute for Biotechnology Front cover, top: HSP90, a regulator of cell survival. Inhibition of HSP90 activity by drugs like geldanamycin (GA) destabilizes client proteins which ultimately lead to the onset of apoptosis. Dana Haley-Vicente, Assay Designs (an Enzo Life Sciences company). Front cover, bottom: C. elegans expressing a proteotoxic polyglutamine- expansion protein. Richard Morimoto, Northwestern University.
    [Show full text]
  • Proteasomes: Unfoldase-Assisted Protein Degradation Machines
    Biol. Chem. 2020; 401(1): 183–199 Review Parijat Majumder and Wolfgang Baumeister* Proteasomes: unfoldase-assisted protein degradation machines https://doi.org/10.1515/hsz-2019-0344 housekeeping functions such as cell cycle control, signal Received August 13, 2019; accepted October 2, 2019; previously transduction, transcription, DNA repair and translation published online October 29, 2019 (Alves dos Santos et al., 2001; Goldberg, 2007; Bader and Steller, 2009; Koepp, 2014). Consequently, any disrup- Abstract: Proteasomes are the principal molecular tion of selective protein degradation pathways leads to a machines for the regulated degradation of intracellular broad array of pathological states, including cancer, neu- proteins. These self-compartmentalized macromolecu- rodegeneration, immune-related disorders, cardiomyo- lar assemblies selectively degrade misfolded, mistrans- pathies, liver and gastrointestinal disorders, and ageing lated, damaged or otherwise unwanted proteins, and (Dahlmann, 2007; Motegi et al., 2009; Dantuma and Bott, play a pivotal role in the maintenance of cellular proteo- 2014; Schmidt and Finley, 2014). stasis, in stress response, and numerous other processes In eukaryotes, two major pathways have been identi- of vital importance. Whereas the molecular architecture fied for the selective removal of unwanted proteins – the of the proteasome core particle (CP) is universally con- ubiquitin-proteasome-system (UPS), and the autophagy- served, the unfoldase modules vary in overall structure, lysosome pathway (Ciechanover, 2005; Dikic, 2017). UPS subunit complexity, and regulatory principles. Proteas- constitutes the principal degradation route for intracel- omal unfoldases are AAA+ ATPases (ATPases associated lular proteins, whereas cellular organelles, cell-surface with a variety of cellular activities) that unfold protein proteins, and invading pathogens are mostly degraded substrates, and translocate them into the CP for degra- via autophagy.
    [Show full text]
  • Metabolomics-Assisted Proteomics Identifies Succinylation and SIRT5 As Important Regulators of Cardiac Function
    Metabolomics-assisted proteomics identifies succinylation and SIRT5 as important regulators of cardiac function Sushabhan Sadhukhana, Xiaojing Liub,c,d, Dongryeol Ryue, Ornella D. Nelsona, John A. Stupinskif, Zhi Lia, Wei Cheng, Sheng Zhangg, Robert S. Weissf, Jason W. Locasaleb,c,d, Johan Auwerxe,1, and Hening Lina,h,1 aDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853; bDuke Cancer Institute, Duke University School of Medicine, Durham, NC 27710; cDuke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC 27710; dDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710; eLaboratory of Integrative and Systems Physiology, School of Life Sciences, École Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland; fDepartment of Biomedical Sciences, Cornell University, Ithaca, NY 14853; gProteomics & Mass Spectrometry Facility, Institute of Biotechnology, Cornell University, Ithaca, NY 14853; and hHoward Hughes Medical Institute, Cornell University, Ithaca, NY 14853 Edited by Kevan M. Shokat, University of California, San Francisco, CA, and approved March 9, 2016 (received for review October 7, 2015) Cellular metabolites, such as acyl-CoA, can modify proteins, leading SIRT4 and SIRT5 have very weak deacetylase activities (14). SIRT5 to protein posttranslational modifications (PTMs). One such PTM is possesses unique enzymatic activity on hydrolyzing negatively lysine succinylation, which is regulated by sirtuin 5 (SIRT5). Although charged
    [Show full text]